Kirsch Janae L, Cerhan James R, Hogan William J, Edwards Holly C, Patten Christi A, Brockman Tabetha, Hughes Christine, Dispenzieri Angela, Ansell Stephen M, Gastineau Dennis A, Ehlers Shawna L
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Cancer Med. 2025 Apr;14(7):e70828. doi: 10.1002/cam4.70828.
To explore pre-hematopoietic stem cell transplant (HSCT) demographic, disease, and psychological factors predictive of future transplant regret and to determine post-HSCT variables associated with regret.
HSCT candidates participated in a prospective cohort study (June 2008-October 2013) examining health behaviors and HSCT outcomes, including completion of standardized surveys at pre-HSCT (baseline) and 1-year post-HSCT. Cases were participants that endorsed regret at 1-year post-HSCT follow-up, and controls were participants without regret at 1 year, matched on age, sex, and transplant type. For cases and controls, pre-HSCT psychosocial evaluations were abstracted from the electronic health record and coded to determine the Psychosocial Assessment of Candidates for Transplantation score, psychosocial stressors, and mental health diagnoses. The association of selected factors with regret was estimated with odds ratios and 95% confidence intervals from conditional logistic regression models.
At post-HSCT, 49 participants of 638 endorsed transplant regret (8%) and formed the case group; 98 controls were matched from remaining participants. Cases and controls were well matched on age (56.6 vs. 57.2 years), sex (both groups 34.7% female), and transplant type (both groups 81.6% autologous). After controlling for the number of hospitalizations and active treatment status, conditional logistic regression revealed that patients who endorsed regret were 3.7 times (95% CI = 1.37-9.69, p = 0.008) more likely to not be in remission compared to controls at 1-year post-HSCT.
Matched case-control analyses revealed that no pre-HSCT variables collected during the pre-HSCT evaluation period were predictive of transplant regret, while poorer outcomes at 1-year after transplant were associated with regret.
探讨造血干细胞移植(HSCT)前的人口统计学、疾病和心理因素对未来移植后悔情绪的预测作用,并确定与后悔情绪相关的HSCT后变量。
HSCT候选者参与了一项前瞻性队列研究(2008年6月至2013年10月),该研究考察健康行为和HSCT结局,包括在HSCT前(基线)和HSCT后1年完成标准化调查。病例为在HSCT后1年随访时认可后悔情绪的参与者,对照组为1年时无后悔情绪的参与者,两组在年龄、性别和移植类型上相匹配。对于病例组和对照组,从电子健康记录中提取HSCT前的心理社会评估信息,并进行编码以确定移植候选者心理社会评估得分、心理社会应激源和心理健康诊断。通过条件逻辑回归模型的比值比和95%置信区间来估计所选因素与后悔情绪的关联。
HSCT后,638名参与者中有49名认可移植后悔情绪(8%),构成病例组;从其余参与者中匹配出98名对照组。病例组和对照组在年龄(56.6岁对57.2岁)、性别(两组女性均占34.7%)和移植类型(两组自体移植均占81.6%)方面匹配良好。在控制住院次数和积极治疗状态后,条件逻辑回归显示,与HSCT后1年的对照组相比,认可后悔情绪的患者病情未缓解的可能性高3.7倍(95%CI = 1.37 - 9.69,p = 0.008)。
配对病例对照分析显示,在HSCT评估期间收集的HSCT前变量均不能预测移植后悔情绪,而移植后1年较差的结局与后悔情绪相关。